Clinical Trial Update: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of DSP107 alone and in combination with atezolizumab. The study targets patients with advanced solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• DSP107
• Tecentriq (atezolizumab)

Snippet

Sponsor: Kahr Medical | Conditions: Advanced Solid Tumor, Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING